Adagene Inc. (ADAG) director Ulf Grawunder granted 20,000 options at $3.00
Rhea-AI Filing Summary
Adagene Inc. reported that director Ulf Grawunder received a grant of 20,000 nonqualified stock options on 2026-08-13. The options carry an exercise price of $3.00 per ordinary share and expire on 2036-08-13. Following this grant, Grawunder holds 85,000 options in total, and the transaction is indicated as made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
1 transaction reported
Mixed
1 txn
Insider
Grawunder Ulf
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Nonqualified Stock Option (Right to Buy) | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Nonqualified Stock Option (Right to Buy) — 85,000 shares (Direct)
Key Figures
Options granted: 20,000 options
Exercise price: $3.00 per share
Expiration date: 2036-08-13
+1 more
4 metrics
Options granted
20,000 options
Nonqualified Stock Option grant on 2026-08-13
Exercise price
$3.00 per share
Exercise price for newly granted options
Expiration date
2036-08-13
Expiration of the 20,000 option grant
Options held after grant
85,000 options
Total derivative holdings following this award
Key Terms
Nonqualified Stock Option, Rule 10b5-1 trading plan, exercise price, expiration date
4 terms
Nonqualified Stock Option financial
"The security is described as a Nonqualified Stock Option (Right to Buy)"
A nonqualified stock option (NQSO) is a company grant that gives an individual the right to buy shares at a set price but does not meet special tax rules for incentive stock options; when exercised the difference between the market price and the exercise price is treated as ordinary income for the recipient and as a tax-deductible expense for the company. It matters to investors because NQSOs affect an employee’s after-tax proceeds, the company’s reported expenses, and potential share dilution—think of it like a cash bonus that converts into stock but is taxed as regular pay when you take it.
Rule 10b5-1 trading plan regulatory
"The transaction is indicated as made under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
exercise price financial
"The options carry an exercise price of $3.00 per ordinary share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"The options have an expiration date of 2036-08-13"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Adagene Inc. (ADAG) disclose about Ulf Grawunder in this Form 4?
Adagene Inc. disclosed that director Ulf Grawunder received a grant of 20,000 nonqualified stock options on 2026-08-13 at an exercise price of $3.00 per share, expiring on 2036-08-13.
How many Adagene (ADAG) options does Ulf Grawunder hold after this grant?
After the reported grant, Ulf Grawunder holds a total of 85,000 nonqualified stock options in Adagene Inc. This figure reflects his derivative holdings following the award of 20,000 additional options reported in this Form 4.
What are the key terms of Ulf Grawunder’s new Adagene (ADAG) stock options?
The new options cover 20,000 ordinary shares at an exercise price of $3.00 per share and have an expiration date of 2036-08-13. They are classified as Nonqualified Stock Options (Right to Buy).
Was Ulf Grawunder’s Adagene (ADAG) option grant under a Rule 10b5-1 plan?
Yes. The filing indicates, via the Rule 10b5-1 checkbox, that the reported derivative grant was affirmed under a trading plan, meaning its terms were pre-arranged in accordance with Rule 10b5-1.
AI-generated analysis. How Rhea-AI works. Not financial advice.
